FOS and metabolic dysfunction-associated steatotic liver disease: Moreover, Ccl2, Fos and Tlr1 are enriched in TNF and TLR signaling pathways, which were significantly decreased KEGG pathways in BMP9-treated NAFLD mouse livers.